Skip to main content
An official website of the United States government

Myeloma Steering Committee Roster

The Myeloma Steering Committee (MYSC) addresses the design, prioritization, and evaluation of concepts for phase 2, 2/3, and 3 clinical trials in adult myeloma. Committee activities help foster collaboration between groups and institutions engaged in conducting trials. The MYSC's membership comprises NCTN group representatives, NCI-funded consortia representatives, community oncologists, Specialized Programs of Research Excellence (SPORE) representatives, biostatisticians, patient advocates, subject matter experts, and NCI staff.



Suzanne Lentzsch, M.D., Ph.D.
Columbia University Medical Center
New York, NY

Noopur Raje, M.D.
Massachusetts General Hospital
Boston, MA

Shaji K. Kumar, M.D. [Chair Emeritus]
Mayo Clinic
Rochester, MN



Sikander Ailawadhi, M.D.
Mayo Clinic
Jacksonville, FL

Leslie Ballas, M.D.
Cedars-Sinai Cancer Institute 
Los Angeles, CA

Ajai Chari, M.D.
Mount Sinai Hospital
New York, NY

Cynthia Chmielewski
Myeloma Patient Advocate 
Lawrenceville, NJ

Adam D. Cohen, M.D.
University of Pennsylvania
Philadelphia, PA

Angela Dispenzieri, M.D.
Mayo Clinic
Rochester, MN

Rafael Fonseca, M.D.
Mayo Clinic
Phoenix, AZ

Boris Freidlin, Ph.D.
National Cancer Institute
Rockville, MD

Susan Geyer, Ph.D.
Mayo Clinic
Rochester, MN

Sergio Giralt, M.D.
Memorial Sloan Kettering Cancer Center
New York, NY

Krisstina Gowin, D.O.
University of Arizona Cancer Center
Tucson, AZ

Michael M.B. Green, M.D.
Kaiser Permanente Oakland Medical Center
Oakland, CA

Antje Hoering, Ph.D.
Cancer Research & Biostatistics
Seattle, WA

Christopher R. Kelsey, M.D.
Duke Cancer Institute
Durham, NC

Richard Little, M.D.
National Cancer Institute
Rockville, MD

Sagar Lonial, M.D.
Emory University
Atlanta, GA

Teresa Miceli, B.S.N., RN, OCN
Myeloma Patient Advocate 
Rochester, MN

Nikhil Munshi, M.D.
Dana-Farber Cancer Institute
Boston, MA

Robert Orlowski, M.D., Ph.D.
University of Texas MD Anderson Cancer Center
Houston, TX

S. Vincent Rajkumar, M.D.
Mayo Clinic
Rochester, MN

Anthony Reiman, M.D., S.M.
Saint John Regional Hospital
Saint John, NB, Canada

Preet Paul Singh, M.D.
Springfield Clinic
Springfield, IL

Edward Stadtmauer, M.D.
University of Pennsylvania Abramson Cancer Center
Philadelphia, PA

Howard Streicher, M.D.
National Cancer Institute
Rockville, MD

Suzanne Trudel, M.D.
University Health Network
Toronto, ON, Canada

Saad Z. Usmani, M.D.
Memorial Sloan Kettering Cancer Center
New York, NY

Christopher P. Venner, M.D.
University of Alberta
Edmonton, AB, Canada

Peter Voorhees, M.D.
Atrium Health Levine Cancer Institute 
Charlotte, NC

NCI CCCT Program Director

Elena Schwartz, Ph.D.


  • Updated: